<DOC>
	<DOCNO>NCT02090621</DOCNO>
	<brief_summary>The purpose study determine safety photopheresis prophylaxis allograft rejection patient withdrawal immunosuppression liver transplantation .</brief_summary>
	<brief_title>Extracorporeal Photopheresis After Liver Transplant</brief_title>
	<detailed_description>The photopheresis ( ECP ) therapeutic approach base biological effect ultraviolet light A mononuclear cell collect apheresis , reinfused patient .</detailed_description>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Liver transplantation 2 year ago &gt; 18 year Treatment immunosuppression ( Cyclosporine tacrolimus ) Normal hepatic function last year No acute chronic rejection secondary effect immunosuppressor Previous disease : alcoholic liver cirrhosis without hepatocarcinoma , metabolic disease , amyloid polyneuropathy , hepatitis , cryptogenic cirrhosis non autoimmune cause Signing consent inform form Additional liver Transplantation hypersensitivity methoxsalen Patients melanoma , cutaneous carcinoma Patients aphakia Patients treat oxsoralen Pregnant woman , lactate woman fertile adult donÂ´t use effective anticonception method Involved assay .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Liver</keyword>
	<keyword>transplantation</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>photopheresis</keyword>
	<keyword>extracorporeal</keyword>
</DOC>